Bamco Inc Adaptive Biotechnologies Corp Transaction History

Bamco Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $8.88 Million - $13 Million	-352,825 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $3.6 Million - $4.78 Million	-120,000 Reduced 25.38%	352,825 $12 Million
Q2 2021 Aug 13, 2021	SELL	$32.22 - $44.59 $1.36 Million - $1.89 Million	-42,333 Reduced 8.22%	472,825 $19.3 Million
Q1 2021 May 19, 2021	SELL	$37.26 - $67.74 $287,796 - $523,223	-7,724 Reduced 1.48%	515,158 $20.7 Million
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $196,108 - $285,252	4,357 Added 0.84%	522,882 $30.9 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $100,212 - $136,668	2,800 Added 0.54%	518,525 $25.2 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $31,212 - $60,523	1,251 Added 0.24%	515,725 $25 Million
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $4.44 Million - $8.93 Million	-261,545 Reduced 33.7%	514,474 $14.3 Million
Q4 2019 Feb 18, 2020	SELL	$24.56 - $32.8 $2.05 Million - $2.74 Million	-83,449 Reduced 9.71%	776,019 $23.2 Million
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $6.14 Million - $10.8 Million	202,668 Added 30.86%	859,468 $26.6 Million
Q2 2019 Aug 15, 2019	BUY	$40.3 - $48.3 $26.5 Million - $31.7 Million	656,800 New	656,800 $31.7 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.